Chr. Hansen
10-12 Bøge Allé
Hørsholm
DK-2970
Denmark
+45 45 74 74 74
HEALTH CATEGORIES
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.
BUSINESS NEWS
02 Feb 2024 --- This week in nutrition news, the merger of Novozyme and Chr. Hansen into the newly minted Novonesis was completed, while legacy Novozymes revealed marked growth for 2023. At the... Read More
NUTRITION & HEALTH NEWS
25 Jan 2024 --- Human milk oligosaccharides (HMOs) — found naturally in human breast milk — are increasingly common in infant dairy formulations looking to offer nutritional benefits... Read More
BUSINESS NEWS
13 Dec 2023 --- The European Commission has cleared the merger between Danish bioscience players Novozymes and Chr. Hansen, conditional upon full compliance with the commitments offered by the... Read More
NUTRITION & HEALTH NEWS
12 Dec 2023 --- As we look forward to ringing in the new year, Nutrition Insight revisits some of the biggest news stories of 2023. From innovative “organ-on-a-chip” advancements to... Read More
FOOD INGREDIENTS NEWS
12 Dec 2023 --- Staple infant nutrition ingredients like demineralized whey and galactooligosaccharide (GOS) fiber are finding fresh applications in food and beverages for the wider population,... Read More
20 Jun 2023 --- Yannik Schönknecht, a scientific advisor at Chr. Hansen, takes us through the latest Human Milk Oligosaccharides (HMOs) research and reveals what is coming up in this field. Schönknecht says that HMOs are prebiotic and have been shown to bring several health benefits independent of the gut microbiome. He predicts that improved technologies and production capabilities will drive the increased interest in the gut microbiome.
12 May 2022 --- Chr. Hansen is expanding the breadth of its portfolio in addition to reinforcing its core portfolio of gut and immune health. Recent studies have revealed the company’s strains have a positive impact on sleep in night shift workers, for example. Linda Neckmar, senior vice president for human health, also flags women’s health as the fastest growing area across regions.
07 Oct 2021 --- Last week, Linda Neckmar was appointed Chr. Hansen’s senior vice president of human health. At Vitafoods Europe 2021, she discusses how the business has been shaped by a chain of acquisitions and a broadened portfolio. Women’s health is a key area of focus, while the company is also looking at expanding more into non-traditional channels like e-commerce.
31 May 2021 --- The “unharmonized” probiotics scene contributes to consumer confusion, which has motivated Chr. Hansen to launch a global online version of The Probiotics Institute. The one-stop-shop educational platform helps consumers navigate the “probiotics jungle” and demystify the human microbiome. Linda Neckmar, VP of commercial development, details why the company has developed a separate version for the Chinese market and how the move coincides with wider company strategies.
07 Mar 2022 --- This week’s NewsBite podcast details how vitamin D supplements could improve sleep quality, a Chr. Hansen study highlighting opportunities in the probiotic space and Danone’s Activia+ Multi-Benefit Drinkable Yogurt launch.
07 Jun 2021 --- This NewsBite podcast delves into Chr. Hansen and Lonza’s joint venture, Bacthera, receiving manufacturing licenses to start supplying live biotherapeutic products. Meanwhile, Probi partnered on probiotic research for vaginal health NPD targeting the “underserved” market. Also, a Safefood report revealed that online conversations about healthy diets are missing input from health experts.
31 Aug 2020 --- This latest episode of NutritionInsight’s NewsBite podcast delves into the top industry news from last week, including proposals for new ways to discuss dietary fiber and synbiotics. There have also been moves in the infant nutrition space from businesses including the a2 Milk Company and Nestlé. Read more:Fiber classification: ICQC report says labeling distinction is “strongly advised”a2 Milk Company grows infant nutrition sector with US$176m Mataura Valley Milk dealChr. Hansen targets “different path” with expansion of microbial capacities
15 Jun 2020 --- In this week’s episode of the NewsBite podcast, NutritionInsight reports on numerous acquisitions, including those from DSM, Chr. Hansen and Nestlé Health Science. Meanwhile, research is booming in spaces including respiratory infections and the microbiome. Read more:DSM snaps up Erber for US$1bn as it prioritizes acquisitionsNestlé Health Science’s HMOs slash respiratory tract infections in infants with cow’s milk protein allergyActiv’Inside in US$19m collaboration to fight cognitive decline in elderly
20 Apr 2020 --- NutritionInsight’s recurring podcast returns to provide the most important industry-related news and information from the past few days. This week, research related to COVID-19 extended into eicosapentaenoic acid free fatty acid, sweet wormwood extract and probiotics, while nutrition companies continue to navigate supply chain disruptions. Read more:Moves for immunity: Chr. Hansen launches online probiotic education platformFatty acid and sweet wormwood on road to clinical trials for COVID-19AHPA reports supply chain disruptions to USDA amid mounting industry concerns
09 May 2023 --- Join this webinar to dive into the scientific field of HMOs and its latest insights. Stina Rikke Jensen, Ph.D., will focus on the signature function of HMOs and present new scientific data. Combined with the new data, Stina will provide an overview of the current evidence on HMOs and discuss how to further substantiate the promising potential of HMOs for food applications.
26 Jan 2023 --- Join this webinar to learn how specific scientifically proven strains like Chr. Hansen’s DDS-1® can support gastrointestinal health and alleviate stress related to gastrointestinal discomfort.Our expert team will walk you through the fascinating connection between the gut and the brain, explain probiotic modes of action, and spotlight the strong clinical evidence on Chr. Hansen’s DDS-1® strain.
27 Oct 2022 --- Probiotics are well-known for their benefits in digestive health, but did you know that 70% of our immune system is located in the gut? There are various ways, in which probiotics can interact with and support the immune system, making it more efficient in responding to immune challenges. This means that consumers who supplement with probiotics may be less susceptible to immune challenges and may recover quicker.Join us for this webinar to learn more about how specific probiotic strains like Chr. Hansen’s L. CASEI 431® can support the body's own defense. Dr. Zonderland will take you through the remarkable connection between the gut and the immune system, explain probiotic modes of action and showcase the strong clinical evidence on Chr. Hansen's L. CASEI 431® strain.
19 Nov 2020 --- There is a complex relationship between the microbiome and immune system, with the right probiotics having the potential to make a major impact. This Chr. Hansen webinar explains what to look for when selecting probiotic strains, as well as examining the clinical studies linking probiotics with the immune system.